News
News

News

10/27/2021 STRATA Skin Sciences to Report Third Quarter 2021 Financial Results on November 10, 2021

STRATA Skin Sciences to Report Third Quarter 2021 Financial Results on November 10, 2021

HORSHAM, Pa. , Oct. 27, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans
10/04/2021 STRATA Skin Sciences Announces CFO Transition

STRATA Skin Sciences Announces CFO Transition

HORSHAM, Pa. , Oct. 04, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that Mr.
09/29/2021 STRATA Skin Sciences to Present at Fall Harvest – Best Ideas from the Buy-Side on Wednesday, October 6th, 2021

STRATA Skin Sciences to Present at Fall Harvest – Best Ideas from the Buy-Side on Wednesday, October 6th, 2021

HORSHAM, Pa. , Sept. 29, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that the Company has been invited to
09/02/2021 STRATA Skin Sciences to Participate in Upcoming Investor Conferences

STRATA Skin Sciences to Participate in Upcoming Investor Conferences

HORSHAM, Pa. , Sept. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in two
08/16/2021 STRATA Skin Sciences Reports Second Quarter 2021 Financial Results

STRATA Skin Sciences Reports Second Quarter 2021 Financial Results

HORSHAM, Pa. , Aug. 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended
08/16/2021 STRATA Skin Sciences Announces Acquisition of the U.S. Dermatology Business of Ra Medical Systems

STRATA Skin Sciences Announces Acquisition of the U.S. Dermatology Business of Ra Medical Systems

Positions STRATA as the predominant provider of excimer laser treatments to address the $6 billion U.S. market for the treatment of chronic skin diseases Delivers added long-term recurring revenue growth potential and prospective customer base Increases competitive positioning with more than 400
08/02/2021 STRATA Skin Sciences to Report Second Quarter 2021 Financial Results on August 16, 2021

STRATA Skin Sciences to Report Second Quarter 2021 Financial Results on August 16, 2021

HORSHAM, Pa. , Aug. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it
08/02/2021 STRATA Skin Sciences Announces Appointment of New VP of Marketing

STRATA Skin Sciences Announces Appointment of New VP of Marketing

HORSHAM, Pa. , Aug. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the
05/12/2021 STRATA Skin Sciences Reports First Quarter 2021 Financial Results

STRATA Skin Sciences Reports First Quarter 2021 Financial Results

HORSHAM, Pa. , May 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended